89bio (NASDAQ:ETNB) Earns Overweight Rating from Cantor …

89bio (NASDAQ:ETNB) Earns Overweight Rating From Cantor …

2 weeks from now

Jan 2, 2025  · 89bio (NASDAQ:ETNB - Get Free Report) 's stock had its "overweight" rating reaffirmed by equities research analysts at Cantor Fitzgerald in a report released on Thursday,Benzinga reports. They presently have a $29.00 target price on the stock. Cantor …

marketbeat.com

89bio (NASDAQ:ETNB) Receives “Overweight” Rating From Cantor …

2 weeks from now

Jan 3, 2025  · Cantor Fitzgerald reaffirmed their overweight rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a report released on Thursday morning,Benzinga reports. The firm currently has a $29.00 ...

defenseworld.net

89bio (NASDAQ:ETNB) Receives “Overweight” Rating From Cantor …

2 weeks from now

Jan 3, 2025  · Cantor Fitzgerald reissued their overweight rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a research note issued to investors on Thursday,Benzinga reports. They currently have a $29.00 price target on the stock. ETNB has been the subject of …

americanbankingnews.com

Cantor Fitzgerald Reiterates Overweight On 89bio, Raises PT To $29

2 weeks from now

Cantor Fitzgerald, a leading financial services firm, has reiterated its overweight rating on 89bio (NASDQ: BTNB), a biotechnology company specializing in gene therapies [1]. The firm's analysts raised their price target for BTNB from $18 to $29, citing the company's promising pipeline and …

ainvest.com

Cantor Fitzgerald Reaffirms Overweight Rating For 89bio …

2 weeks from now

Jul 5, 2024  · Cantor Fitzgerald reaffirmed their overweight rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a research report report published on Monday, Benzinga reports. They currently have a $29.00 target price on the stock. Several other research firms …

mayfieldrecorder.com

Cantor Fitzgerald Reiterates Overweight Rating For 89bio …

2 weeks from now

Jun 13, 2024  · Cantor Fitzgerald restated their overweight rating on shares of 89bio (NASDAQ:ETNB – Free Report) in a report published on Wednesday morning, Benzinga reports. Cantor Fitzgerald currently has a $29.00 price objective on the stock. Other research analysts …

americanbankingnews.com

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed By Cantor Fitzgerald

2 weeks from now

May 19, 2024  · 89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a note issued to investors on Friday, Benzinga reports. They currently have a $29.00 price target on the stock. Cantor Fitzgerald’s target price …

americanbankingnews.com

89bio (NASDAQ:ETNB) Receives Overweight Rating From Cantor …

2 weeks from now

Jun 12, 2024  · 89bio (NASDAQ:ETNB) received an "overweight" rating and a $29.00 price target from Cantor Fitzgerald. Other analysts have also commented on ETNB, with two holding a hold rating and five giving it a buy rating. The stock is currently trading at $9.84 with a 52-week low …

longportapp.com

Cantor Fitzgerald Reiterates Overweight On 89bio, Maintains $29 …

2 weeks from now

Jan 2, 2025  · Cantor Fitzgerald analyst Kristen Kluska reiterates 89bio (NASDAQ:ETNB) with a Overweight and maintains $29 price target.

sahmcapital.com

89bio: Cantor Fitzgerald Reiterates The 'Overweight' Rating, The …

2 weeks from now

Overweight $29 [Recent Earning Results] 89bio posted the Q3 of its 2024 financial results on 11/7/2024, reporting net income of USD -248.73 million in the first three quarters, expanding 143.96% from USD -101.95 million year over year.

ainvest.com

89bio (NASDAQ:ETNB) Trading Down 8.2% - Here's What …

2 weeks from now

6 days ago  · Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $29.00 target price on shares of 89bio in a report on Thursday, January 2nd. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong …

marketbeat.com

Cantor Fitzgerald Maintains 89bio (ETNB) Overweight …

2 weeks from now

Apr 24, 2023  · Fintel reports that on May 5, 2023, Cantor Fitzgerald maintained coverage of 89bio (NASDAQ:ETNB) with a Overweight recommendation.. Analyst Price Forecast Suggests 111.86% Upside. As of April 24 ...

nasdaq.com

Cantor Fitzgerald Reiterates Overweight Rating For 89bio

2 weeks from now

Cantor Fitzgerald Reiterates Overweight Rating for 89bio (NASDAQ:ETNB) Defense World · 11/16/2022 14:51. 89bio +4.25%. 89bio (NASDAQ:ETNB – Get Rating) 's stock had its "overweight" rating reiterated by analysts at Cantor Fitzgerald in a research note issued to …

moomoo.com

Stock Picks & Analyst Ratings From Cantor Fitzgerald - MarketBeat

2 weeks from now

View details for Cantor Fitzgerald rating of 89bio (NASDAQ:ETNB) on 1/2/2025: RCEL. AVITA Medical. $8.76-0.7%: 12/24/2024: Reiterated by: Cantor Fitzgerald-Overweight -> Overweight: ... Cantor Fitzgerald-Overweight -> Overweight: $350.00 -> $370.00: N/A: View details for Cantor …

marketbeat.com

Cantor Starts 89bio At OW; PT $58 - BioTuesdays

2 weeks from now

Apr 21, 2021  · Cantor Fitzgerald launched coverage of 89bio (NASDAQ:ETNB) with an “overweight” rating and $58 price target. The stock closed at $25.81 on April 20. 89bio is developing BIO89-100, its injectable FGF21 hormone analog, which is entering a Phase 2b …

biotuesdays.com

Cantor Fitzgerald Adjusts Price Target On 89bio To $41 From $49 ...

2 weeks from now

Cantor Fitzgerald Adjusts Price Target on 89bio to $41 From $49, Reiterates Overweight Rating

webull.com